VCA Inc. (NASDAQ:WOOF) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Friday. The brokerage currently has a $77.00 target price on the stock. Zacks Investment Research’s price objective indicates a potential upside of 10.28% from the stock’s current price.
According to Zacks, “VCA Inc. is a national animal healthcare company operating primarily in the United States and Canada. It owns, operates and manages veterinary hospitals and veterinary-exclusive clinical laboratories in the country, supplies diagnostic imaging equipment and other medical technology products and related services to the veterinary industry, and provides various communication, professional education and marketing solutions to the veterinary community. VCA Inc., formerly known as VCA Antech, Inc., is headquartered in Los Angeles, California. “
A number of other analysts have also commented on WOOF. Jefferies Group initiated coverage on VCA in a report on Wednesday, June 8th. They set a “hold” rating for the company. Bank of America Corp. reissued a “buy” rating on shares of VCA in a report on Thursday, September 29th. One research analyst has rated the stock with a hold rating and six have issued a buy rating to the company. VCA has an average rating of “Buy” and a consensus price target of $71.00.
VCA (NASDAQ:WOOF) opened at 69.82 on Friday. The firm has a market cap of $5.65 billion, a price-to-earnings ratio of 24.91 and a beta of 1.23. VCA has a 1-year low of $44.00 and a 1-year high of $73.69. The firm has a 50-day moving average price of $70.32 and a 200 day moving average price of $66.04.
VCA (NASDAQ:WOOF) last issued its quarterly earnings data on Wednesday, July 27th. The company reported $0.87 EPS for the quarter, topping analysts’ consensus estimates of $0.82 by $0.05. The firm earned $653.50 million during the quarter, compared to analyst estimates of $637.18 million. VCA had a return on equity of 16.86% and a net margin of 9.93%. The company’s revenue for the quarter was up 19.1% on a year-over-year basis. During the same period in the previous year, the company posted $0.70 EPS. Equities analysts predict that VCA will post $2.93 earnings per share for the current year.
In other news, COO Arthur J. Antin sold 34,000 shares of the company’s stock in a transaction that occurred on Friday, September 16th. The stock was sold at an average price of $69.03, for a total value of $2,347,020.00. Following the completion of the transaction, the chief operating officer now directly owns 89,691 shares of the company’s stock, valued at $6,191,369.73. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director John B. Chickering, Jr. sold 2,302 shares of the company’s stock in a transaction that occurred on Thursday, August 4th. The shares were sold at an average price of $70.85, for a total value of $163,096.70. Following the completion of the transaction, the director now directly owns 10,992 shares of the company’s stock, valued at $778,783.20. The disclosure for this sale can be found here. 4.60% of the stock is owned by insiders.
Several institutional investors have recently added to or reduced their stakes in WOOF. Mason Street Advisors LLC acquired a new position in VCA during the second quarter valued at about $2,492,000. Royal Bank of Canada raised its position in shares of VCA by 148.6% in the second quarter. Royal Bank of Canada now owns 42,110 shares of the company’s stock valued at $2,847,000 after buying an additional 25,169 shares during the period. Sterling Capital Management LLC raised its position in shares of VCA by 29.3% in the second quarter. Sterling Capital Management LLC now owns 4,676 shares of the company’s stock valued at $317,000 after buying an additional 1,061 shares during the period. Braun Stacey Associates Inc. raised its position in shares of VCA by 28.5% in the second quarter. Braun Stacey Associates Inc. now owns 257,715 shares of the company’s stock valued at $17,424,000 after buying an additional 57,120 shares during the period. Finally, Calvert Investment Management Inc. raised its position in shares of VCA by 7.7% in the second quarter. Calvert Investment Management Inc. now owns 4,633 shares of the company’s stock valued at $313,000 after buying an additional 333 shares during the period. 91.17% of the stock is owned by institutional investors.
VCA Inc is an animal healthcare company. The Company operates through five segments. Its Animal Hospital segment provides veterinary services for companion animals and sells related retail and pharmaceutical products. Its Laboratory segment provides diagnostic laboratory testing services for veterinarians, both associated with its animal hospitals and those independent of the Company.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for VCA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VCA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.